The stock's fall snapped a two-day winning streak.

Experts told BI Rite Aid's financial problems were worsened by the larger industry shifts facing drugstore chains.

CVS Health Corp.’s drug-benefits unit negotiated a deal to make Novo Nordisk A/S’s Wegovy more widely available to its ...

CVS reported first quarter earnings Thursday, blowing past Wall Street's expectations and ending anxiety over Medicare ...

Eli Lilly shares dropped Thursday as Novo Nordisk notched a coverage win for its obesity drug, a sign of the competition in ...

This was the stock's third consecutive day of losses.